Literature DB >> 12568750

Prevalence of Clostridium botulinum types B, E and F in faecal samples from Swedish cattle.

Maria Dahlenborg1, Elisabeth Borch, Peter Rådström.   

Abstract

Faeces were collected from 60 cows at three slaughterhouses situated in southern and central Sweden. The faecal samples were collected during two sampling periods over the year, summer and winter. All samples were analysed for the presence of Clostridium botulinum spores, according to a combined selection and enrichment PCR procedure. One PCR assay was specific for part of the type B neurotoxin gene, while the other assay was specific for both type E and F neurotoxin genes. The prevalence of C. botulinum in Swedish cattle was established to be 73% for non-proteolytic type B and less than 5% for types E and F. Twenty-eight (64%) of the positive faecal samples had a spore load of less than 4 spores/g. Statistical analysis (ANOVA) showed that seasonal variation (summer and winter) had a significant effect on the prevalence of C. botulinum type B in cattle, whereas the effect of geographical location of rearing of the cattle (southern and central Sweden) was less significant.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12568750     DOI: 10.1016/s0168-1605(02)00255-6

Source DB:  PubMed          Journal:  Int J Food Microbiol        ISSN: 0168-1605            Impact factor:   5.277


  11 in total

1.  Sensitive detection of botulinum neurotoxin types C and D with an immunoaffinity chromatographic column test.

Authors:  Frank Gessler; Katrin Hampe; Helge Böhnel
Journal:  Appl Environ Microbiol       Date:  2005-12       Impact factor: 4.792

2.  Diversity of culturable psychrophilic and psychrotrophic anaerobic bacteria isolated from beef abattoirs and their environments.

Authors:  G Moschonas; D J Bolton; D A McDowell; J J Sheridan
Journal:  Appl Environ Microbiol       Date:  2011-04-15       Impact factor: 4.792

3.  The influence of glyphosate on the microbiota and production of botulinum neurotoxin during ruminal fermentation.

Authors:  Wagis Ackermann; Manfred Coenen; Wieland Schrödl; Awad A Shehata; Monika Krüger
Journal:  Curr Microbiol       Date:  2014-11-19       Impact factor: 2.188

4.  Quantitative analysis of levels of serum immunoglobulin G against botulinum neurotoxin type D and association with protection in natural outbreaks of cattle botulism.

Authors:  A Steinman; M Chaffer; D Elad; N Y Shpigel
Journal:  Clin Vaccine Immunol       Date:  2006-08

5.  Detection of Clostridium botulinum in liquid manure and biogas plant wastes.

Authors:  Jürgen Neuhaus; Wieland Schrödl; Awad A Shehata; Monika Krüger
Journal:  Folia Microbiol (Praha)       Date:  2015-03-10       Impact factor: 2.099

Review 6.  Laboratory diagnostics of botulism.

Authors:  Miia Lindström; Hannu Korkeala
Journal:  Clin Microbiol Rev       Date:  2006-04       Impact factor: 26.132

7.  Relative neurotoxin gene expression in clostridium botulinum type B, determined using quantitative reverse transcription-PCR.

Authors:  Maria Lövenklev; Elisabet Holst; Elisabeth Borch; Peter Rådström
Journal:  Appl Environ Microbiol       Date:  2004-05       Impact factor: 4.792

Review 8.  Human Botulism in France, 1875-2016.

Authors:  Christine Rasetti-Escargueil; Emmanuel Lemichez; Michel R Popoff
Journal:  Toxins (Basel)       Date:  2020-05-21       Impact factor: 4.546

9.  Detailed analysis of metagenome datasets obtained from biogas-producing microbial communities residing in biogas reactors does not indicate the presence of putative pathogenic microorganisms.

Authors:  Felix G Eikmeyer; Antje Rademacher; Angelika Hanreich; Magdalena Hennig; Sebastian Jaenicke; Irena Maus; Daniel Wibberg; Martha Zakrzewski; Alfred Pühler; Michael Klocke; Andreas Schlüter
Journal:  Biotechnol Biofuels       Date:  2013-04-04       Impact factor: 6.040

Review 10.  Public Health Risk Associated with Botulism as Foodborne Zoonoses.

Authors:  Christine Rasetti-Escargueil; Emmanuel Lemichez; Michel R Popoff
Journal:  Toxins (Basel)       Date:  2019-12-30       Impact factor: 4.546

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.